The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Open accessAbstract
Background Neurofibrillary pathology has a stereotypical progression in Alzheimer's disease (AD) that is encapsulated in the Braak staging scheme; however, some AD cases are atypical and do not fit into this scheme. We aimed to compare clinical and neuropathological features between typical and atypical AD cases.Methods AD cases with a Braak neurofibrillary tangle stage of more than IV were identified from a brain bank database. By use of thioflavin-S fluorescence microscopy, we assessed the density and the distribution of neurofibrillary tangles in three cortical regions and two hippocampal sectors. These data were used to construct an algorithm to classify AD cases into typical, hippocampal sparing, or limbic predominant. Classified cases were then compared for clinical, demographic, pathological, and genetic characteristics. An independent cohort of AD cases was assessed to validate findings from the initial cohort.Findings 889 cases of AD, 398 men and 491 women with age at death of 37-103 years, were classified with the algorithm as hippocampal sparing (97 cases [11%]), typical (665 [75%]), or limbic predominant (127 [14%]). By comparison with typical AD, neurofibrillary tangle counts per 0.125 mm(2) in hippocampal sparing cases were higher in cortical areas (median 13, IQR 11-16) and lower in the hippocampus (7.5, 5.2-9.5), whereas counts in limbic-predominant cases were lower in cortical areas (4.3, 3.0-5.7) and higher in the hippocampus (27, 22-35). Hippocampal sparing cases had less hippocampal atrophy than did typical and limbic-predominant cases. Patients with hippocampal sparing AD were younger at death (mean 72 years [SD 10]) and a higher proportion of them were men (61 [63%]), whereas those with limbic-predominant AD were older (mean 86 years [SD 6]) and a higher proportion of them were women (87 [69%]). Microtubule-associated protein tau (MAPT) H1H1 genotype was more common in limbic-predominant AD (54 [70%]) than in hippocampal sparing AD (24 [46%]; p=0.011), but did not differ significantly between limbic-predominant and typical AD (204 [59%]; p=0.11). Apolipoprotein E (APOE) ɛ4 allele status differed between AD subtypes only when data were stratified by age at onset. Clinical presentation, age at onset, disease duration, and rate of cognitive decline differed between the AD subtypes. These findings were confirmed in a validation cohort of 113 patients with AD.Interpretation These data support the hypothesis that AD has distinct clinicopathological subtypes. Hippocampal sparing and limbic-predominant AD subtypes might account for about 25% of cases, and hence should be considered when designing clinical, genetic, biomarker, and treatment studies in patients with AD.Funding US National Institutes of Health via Mayo Alzheimer's Disease Research Center, Mayo Clinic Study on Aging, Florida Alzheimer's Disease Research Center, and Einstein Aging Study; and State of Florida Alzheimer's Disease Initiative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“clinical features lack specificity for a pathologic process, but rather indicate brain regions or systems affected by the disease process [3, 4].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Three major subtypes of AD can be classified by the relative density of hippocampal neurofibrillary tangles with respect to neocortical tangles [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Genetic analyses of APOE suggest APOE4 is more closely linked to typical or limbic predominant than hippocampal sparing AD [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Nonamnestic clinical presentations, that is, language, visuospatial, and executive disorders, may also be due to AD [63–66].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [65]
In the citing paper
“Another challenge of CPC studies is that the molecular, anatomic, and clinical changes of AD may not progress in a uniform fashion (7, 12-15).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“and that not all AD cases fall within the same spatial continuum with regard to brain NFT distributions (12, 15, 151).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“Nevertheless, Braak staging also masks the fact that marked variability in pathologic lesion density across cases exists within a given Braak stage (7, 12)”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
Self-citationAssociation of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Self-citationBarker, W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 714
Self-citation
Cited by
Sorted by citations
Items 201–300 of 971
Moloney, C. M., Labuzan, S. A., Crook, J. E., Siddiqui, H., Castanedes‐Casey, M., Lachner, C., Petersen, R. C., Duara, R., Graff‐Radford, N. R., Dickson, D. W., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12749 · Cited by 76
Self-citationYang, Z., Slavin, M. J., & Sachdev, P. S. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.105 · Cited by 74
Guzman, V. A., Carmichael, O. T., Schwarz, C. G., Tosto, G., Zimmerman, M. E., Brickman, A. M., & Initiative, A. D. N. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.009 · Cited by 77
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies
Villemagne, V. L., Leuzy, A., Bohorquez, S. M. S., Bullich, S., Shimada, H., Rowe, C. C., Bourgeat, P., Lopresti, B. J., Huang, K., Krishnadas, N., et al. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12454 · Cited by 72
Incidence of stroke in people with Alzheimer disease
Tolppanen, A., Lavikainen, P., Solomon, A., Kivipelto, M., Soininen, H. S., & Hartikainen, S. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f08c5 · Cited by 75
MRI-assessed atrophy subtypes in Alzheimer’s disease and the cognitive reserve hypothesis
Persson, K., Eldholm, R. S., Barca, M. L., Cavallin, L., Ferreira, D., Knapskog, A., Selbæk, G., Brækhus, A., Saltvedt, I. T., Westman, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186595 · Cited by 73
Ni, R., Ji, B., Ono, M., Sahara, N., Zhang, M.-R., Aoki, I., Nordberg, A., Suhara, T., & Higuchi, M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.201632 · Cited by 72
Distribution of Pathology in Frontal Variant Alzheimer's Disease
Blennerhassett, R. C., Lillo, P., Halliday, G. M., Hodges, J. R., & Kril, J. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131241 · Cited by 74
Ferman, T. J., Arvanitakis, Z., Fujishiro, H., Duara, R., Parfitt, F. C., Purdy, M., Waters, C., Barker, W., Graff‐Radford, N. R., & Dickson, D. W. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.10.013 · Cited by 71
Self-citationOssenkoppele, R., Mattsson, N., Teunissen, C. E., Barkhof, F., Pijnenburg, Y. A. L., Scheltens, P., van der Flier, W. M., & Rabinovici, G. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.011 · Cited by 76
Wu, B.-S., Zhang, Y.-R., Li, H.-Q., Kuo, K., Chen, S.-D., Dong, Q., Liu, Y., & Yu, J.-T. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01599-x · Cited by 69
Koychev, I. G., on behalf of the Deep and Frequent Phenotyping study team (http://www.dementiastudy.co.uk/), Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B. H., Sahakian, B. J., Rowe, J. B., Thomas, A. J., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170129 · Cited by 67
“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
Rao, C. V., Asch, A. S., Carr, D. J. J., & Yamada, H. Y. (2020) · Aging Cell · doi:10.1111/acel.13109 · Cited by 69
Pathobiological Subtypes of Alzheimer Disease
Jellinger, K. A. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000508625 · Cited by 69
Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease
Phillips, J. S., Das, S. R., McMillan, C. T., Irwin, D. J., Roll, E. E., Da Re, F., Nasrallah, I. M., Wolk, D. A., & Grossman, M. (2018) · Human Brain Mapping · doi:10.1002/hbm.23874 · Cited by 68
Cavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack Jr, C. R., Sperling, R., Cummings, J., Blennow, K., et al. (2014) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2014.32 · Cited by 67
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
Ayuso, V. E., Pickles, S. R., Todd, T. W., Yue, M., Jansen‐West, K. R., Song, Y., Bejarano, J. G., Rawlinson, B. D., Deture, M. A., Graff‐Radford, N. R., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00646-z · Cited by 69
Self-citationTDP-43 pathology is associated with increased tau burdens and seeding
Tomé, S. O., Tsaka, G., Ronisz, A., Ospitalieri, S., Gawor, K., Gomes, L. A., Otto, M., Arnim, C. A. F. V., Damme, P. V., Bosch, L. V. D., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00653-0 · Cited by 74
Phenotypic Profile of Early-Onset Familial Alzheimer's Disease Caused by Presenilin-1 E280A Mutation
Sepulveda-Falla, D., Glatzel, M., & Lopera, F. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120907 · Cited by 75
Ferreira, D., Shams, S., Cavallin, L., Viitanen, M. H., Martola, J., Granberg, T., Shams, M., Aspelin, P., Wiberg, M. K., Nordberg, A. K., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.028 · Cited by 65
Tredici, K. D., & Braak, H. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.008 · Cited by 68
The cholinergic system in subtypes of Alzheimer’s disease: an in vivo longitudinal MRI study
Machado, A., Ferreira, D., Grothe, M. J., Eyjolfsdottir, H., Almqvist, P. M., Cavallin, L., Lind, G., Lind, G., Seiger, Å., Teipel, S., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00620-7 · Cited by 65
Multi-scale semi-supervised clustering of brain images: Deriving disease subtypes
Wen, J., Varol, E., Sotiras, A., Yang, Z., Chand, G. B., Erus, G., Shou, H., Abdulkadir, A., Hwang, G., Dwyer, D., et al. (2021) · Medical Image Analysis · doi:10.1016/j.media.2021.102304 · Cited by 68
rAAV-based brain slice culture models of Alzheimer’s and Parkinson’s disease inclusion pathologies
Croft, C. L., Cruz, P. E., Ryu, D. H., Ceballos‐Diaz, C., Strang, K. H., Woody, B. M., Lin, W.-L., Deture, M. A., Rodríguez-Lebrón, E., Dickson, D. W., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182184 · Cited by 65
Self-citationPrimary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers
Magnin, É., Démonet, J., Wallon, D., Dumurgier, J., Troussière, A., Jager, A., Duron, E., Gabelle, A., Sayette, V. D. L., Volpe‐Gillot, L., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160536 · Cited by 61
Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study
Pievani, M., Bocchetta, M., Boccardi, M., Cavedo, E., Bonetti, M., Thompson, P. M., & Frisoni, G. B. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.016 · Cited by 62
Topographic staging of tau positron emission tomography images
Schwarz, A. J., Shcherbinin, S., Slieker, L. J., Risacher, S. L., Charil, A., Irizarry, M. C., Fleisher, A., Southekal, S. S., Joshi, A. D., Devous, M. D., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.01.006 · Cited by 63
Chaudhary, S., Zhornitsky, S., Chao, H. H., van Dyck, C. H., & Li, C. R. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221082834 · Cited by 66
Ross, J. A., Gliebus, G. P., & Bockstaele, E. J. V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.004 · Cited by 63
Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
Contador, J., Pérez‐Millan, A., Tort‐Merino, A., Balasa, M., Falgàs, N., Olives, J., Castellví, M., Borrego‐Écija, S., Bosch, B., Fernández‐Villullas, G., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102804 · Cited by 64
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
Aksman, L., Oxtoby, N. P., Scelsi, M. A., Wijeratne, P. A., Young, A. L., Alves, I. L., Collij, L. E., Vogel, J. W., Barkhof, F., Alexander, D. C., et al. (2023) · Brain · doi:10.1093/brain/awad232 · Cited by 69
18 F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease
Nasrallah, I. M., Chen, Y. J., Hsieh, M.-K., Phillips, J. S., Ternes, K., Stockbower, G. E., Sheline, Y., McMillan, C. T., Grossman, M., & Wolk, D. A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.194282 · Cited by 60
Cerami, C., Dubois, B., Boccardi, M., Monsch, A. U., Démonet, J., & Cappa, S. F. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.034 · Cited by 64
Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
Jeon, S., Kang, J. M., Seo, S., Jeong, H. J., Funck, T., Lee, S., Park, K. H., Lee, Y., Yeon, B. K., Ido, T., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00211 · Cited by 59
Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment
Kantarci, K., Lesnick, T. G., Ferman, T. J., Przybelski, S. A., Boeve, B. F., Smith, G. E., Kremers, W. K., Knopman, D. S., Jack, C. R., & Petersen, R. C. (2016) · Neurology · doi:10.1212/wnl.0000000000003371 · Cited by 59
Self-citationNeuropathological fingerprints of survival, atrophy and language in primary progressive aphasia
Mesulam, M. M., Coventry, C., Bigio, E. H., Sridhar, J., Gill, N. P., Fought, A. J., Zhang, H., Thompson, C. K., Geula, C., Gefen, T. D., et al. (2021) · Brain · doi:10.1093/brain/awab410 · Cited by 63
Gunnarsson, M. D., Lannfelt, L., Ingelsson, M., Basun, H., & Kilander, L. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000355556 · Cited by 56
Ferrando, R., & Damián, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.629442 · Cited by 59
The heterogeneity within Alzheimer's disease
Ferreira, D., Wahlund, L., & Westman, E. (2018) · Aging · doi:10.18632/aging.101638 · Cited by 57
Pillai, J. A., Bonner‐Jackson, A., Bekris, L. M., Safar, J., Bena, J., & Leverenz, J. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190519 · Cited by 56
Belonwu, S., Li, Y., Bunis, D. G., Rao, A. A., Solsberg, C. W., Tang, A., Fragiadakis, G. K., Dubal, D. B., Oskotsky, T., & Sirota, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02591-8 · Cited by 55
Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
Shakir, M., & Dugger, B. N. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab122 · Cited by 58
Murray, M. E., Moloney, C. M., Kouri, N., Syrjanen, J. A., Matchett, B. J., Rothberg, D. M., Tranovich, J. F., Sirmans, T. N. H., Wiste, H. J., Boon, B. D. C., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00578-0 · Cited by 58
Self-citationClinical Trials in Predementia Stages of Alzheimer Disease
Pillai, J. A., & Cummings, J. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.01.002 · Cited by 58
Alzheimer's disease neuroimaging
Whitwell, J. L. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000570 · Cited by 67
Capatina, L., Todirașcu-Ciornea, E., Napoli, E., Ruberto, G., Hriţcu, L., & Dumitru, G. (2020) · Antioxidants · doi:10.3390/antiox9111083 · Cited by 56
Hara, M., Hirokawa, K., Kamei, S., & Uchihara, T. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1097-6 · Cited by 55
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
Wolf, A. B., Valla, J., Bu, G., Kim, J., LaDu, M., Reiman, E. M., & Caselli, R. J. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt204 · Cited by 55
Tort‐Merino, A., Falgàs, N., Allen, I. E., Balasa, M., Olives, J., Contador, J., Castellví, M., Juncà‐Parella, J., Guillén, N., Borrego‐Écija, S., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51689 · Cited by 55
The biomarker-based diagnosis of Alzheimer's disease. 2—lessons from oncology
Boccardi, M., Gallo, V., Yasui, Y., Vineis, P., Padovani, A., Mosimann, U. P., Giannakopoulos, P., Gold, G., Dubois, B., Jack, C. R., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.021 · Cited by 56
Camargo, A., Initiative, A. D. N., & Wang, Z. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210116 · Cited by 58
Tombini, M., Assenza, G., Ricci, L., Lanzone, J., Boscarino, M., Vico, C., Magliozzi, A., & Lazzaro, V. D. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200286 · Cited by 54
Yang, Z., Wen, J., Abdulkadir, A., Cui, Y., Erus, G., Mamourian, E., Melhem, R., Srinivasan, D., Govindarajan, S. T., Chen, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44271-2 · Cited by 55
The power of neuroimaging biomarkers for screening frontotemporal dementia
McMillan, C. T., Avants, B., Cook, P. A., Ungar, L., Trojanowski, J. Q., & Grossman, M. (2014) · Human Brain Mapping · doi:10.1002/hbm.22515 · Cited by 58
Amyloid Imaging in Atypical Presentations of Alzheimer’s Disease
Wolk, D. A. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0412-x · Cited by 54
Garg, N., Choudhry, M. S., & Bodade, R. M. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109745 · Cited by 61
Protocol for the Rare Dementia Support Impact study: RDS Impact
Brotherhood, E., Stott, J. C. H., Windle, G., Barker, S., Culley, S., Harding, E., Camic, P. M., Caufield, M., Ezeofor, V. ‘., Hoare, Z., et al. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5253 · Cited by 52
Dickerson, B. C., Brickhouse, M. J., McGinnis, S. M., Wolk, D. A., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.007 · Cited by 55
Thomas, D. X., Bajaj, S., McRae‐McKee, K., Hadjichrysanthou, C., Anderson, R. M., & Collinge, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-71305-2 · Cited by 53
Neuroimaging in aging and neurologic diseases
Risacher, S. L., & Saykin, A. J. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00012-1 · Cited by 56
Xu, M., Sanz, D. L., Garcés, P., Maestú, F., Li, Q., & Pantazis, D. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3049199 · Cited by 51
Paeonol Suppresses Neuroinflammatory Responses in LPS-Activated Microglia Cells
He, L. X., Tong, X., Zeng, J., Tu, Y., Wu, S., Li, M., Deng, H., Zhu, M., Li, X., Nie, H., et al. (2016) · Inflammation · doi:10.1007/s10753-016-0426-z · Cited by 51
Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes
Edmonds, E. C., Weigand, A. J., Hatton, S. N., Marshall, A. J., Thomas, K. R., Ayala, D. A., Bondi, M. W., McDonald, C. R., & Initiative, A. D. N. (2020) · Neurology · doi:10.1212/wnl.0000000000009462 · Cited by 53
McDade, E. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001131 · Cited by 56
Timmers, T., Ossenkoppele, R., Wolters, E. E., Verfaillie, S. C. J., Visser, D., Golla, S. S. V., Barkhof, F., Scheltens, P., Boellaard, R., van der Flier, W. M., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0510-3 · Cited by 55
Therriault, J., Pascoal, T. A., Savard, M., Benedet, A. L., Chamoun, M., Tissot, C., Lussier, F. Z., Kang, M. S., Thomas, E. M., Terada, T., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011081 · Cited by 53
Na, H. K., Kang, D. R., Kim, S. S., Seo, S. W., Heilman, K. M., Noh, Y., & Na, D. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.001 · Cited by 49
Win, K., Pluta, J. B., Yushkevich, P. A., Irwin, D. J., McMillan, C. T., Rascovsky, K., Wolk, D. A., & Grossman, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00330 · Cited by 49
Neuroinflammation is increased in the parietal cortex of atypical Alzheimer’s disease
Boon, B. D. C., Hoozemans, J. J. M., Lopuhaä, B. V., Eigenhuis, K. N., Scheltens, P., Kamphorst, W., Rozemüller, A. J. M., & Bouwman, F. H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1180-y · Cited by 52
van Rooij, J., Meeter, L. H. H., Melhem, S., Nijholt, D. A. T., Wong, T. H., Rozemüller, A. J. M., Uitterlinden, A. G., van Meurs, J. B. J., & Swieten, J. C. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.023 · Cited by 47
The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease
Whitwell, J. L., Martin, P. R., Graff‐Radford, J., Machulda, M. M., Senjem, M. L., Schwarz, C. G., Weigand, S. D., Spychalla, A. J., Drubach, D. A., Jack, C. R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.12.016 · Cited by 48
Breakdown of specific functional brain networks in clinical variants of Alzheimer’s disease
Pini, L., Wennberg, A. M. V., Salvalaggio, A., Vallesi, A., Pievani, M., & Corbetta, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101482 · Cited by 48
Aziz, A.-L., Giusiano, B., Joubert, S., Duprat, L., Didic, M., Guériot, C., Koric, L., Boucraut, J., Félician, O., Ranjeva, J., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.02.010 · Cited by 48
Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer’s disease
Phillips, J. S., Re, F. D., Irwin, D. J., McMillan, C. T., Vaishnavi, S., Xie, S. X., Lee, E. B., Cook, P. A., Gee, J. C., Shaw, L. M. J., et al. (2019) · Brain · doi:10.1093/brain/awz091 · Cited by 51
Hickman, R. A., Flowers, X. E., & Wısnıewskı, T. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01063-1 · Cited by 48
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2021) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2021.630172 · Cited by 47
Touroutoglou, A., Katsumi, Y., Brickhouse, M. J., Zaitsev, A., Eckbo, R., Aisen, P. S. S., Beckett, L. A., Dage, J. L., Eloyan, A., Foroud, T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13466 · Cited by 47
Self-citationEarly- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?
Valdez-Gaxiola, C. A., Rosales-Leycegui, F., Gaxiola-Rubio, A., Moreno-Ortíz, J. M., & Figuera, L. E. (2024) · Diseases · doi:10.3390/diseases12060110 · Cited by 55
Sun, N., Mormino, E. C., Chen, J., Sabuncu, M. R., & Yeo, B. T. T. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116043 · Cited by 47
From beta amyloid to altered proteostasis in Alzheimer’s disease
Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47
Mitochondria-Targeted Delivery Strategy of Dual-Loaded Liposomes for Alzheimer’s Disease Therapy
Vasileva, L. A., Gaynanova, G. A., Valeeva, F. G., Belyaev, G. P., Zueva, I. V., Bushmeleva, K., Sibgatullina, G., Samigullin, D., Vyshtakalyuk, A. B., Petrov, K. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310494 · Cited by 48
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Pontecorvo, M. J., Siderowf, A. D., Dubois, B., Doraiswamy, P. M., Frisoni, G. B., Grundman, M., Nobili, F. M., Sadowsky, C., Salloway, S., Arora, A., et al. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000478007 · Cited by 46
Patterns of progressive atrophy vary with age in Alzheimer's disease patients
Fiford, C. M., Ridgway, G. R., Cash, D. M., Marc Modat, A., Nicholas, J. M., Manning, E. N., Malone, I. B., Biessels, G. J., Sebastien Ourselin, A., Carmichael, O. T., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.002 · Cited by 46
Alzheimer’s genes in microglia: a risk worth investigating
Sudwarts, A., & Thinakaran, G. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00679-4 · Cited by 52
Neuropathological subtypes of Alzheimer’s disease
Jellinger, K. A. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0889-9 · Cited by 45
Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife
Racine, A. M., Koscik, R. L., Berman, S. E., Nicholas, C. R. N., Clark, L. R., Okonkwo, O. C., Rowley, H. A., Asthana, S., Bendlin, B. B., Blennow, K., et al. (2016) · Brain · doi:10.1093/brain/aww142 · Cited by 46
Linguistic Aspects of Primary Progressive Aphasia
Grossman, M. (2017) · Annual Review of Linguistics · doi:10.1146/annurev-linguistics-011516-034253 · Cited by 46
Bhagwat, N., Pipitone, J., Voineskos, A. N., Chakravarty, M. M., & Initiative, A. D. N. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180016 · Cited by 47
Altered cerebral blood flow in older adults with Alzheimer’s disease: a systematic review
Swinford, C. G., Risacher, S. L., Wu, Y., Apostolova, L. G., Gao, S., Bice, P. J., & Saykin, A. J. (2022) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00750-6 · Cited by 44
Clark, L. R., Stricker, N. H., Libon, D. J., Delano‐Wood, L., Salmon, D. P., Delis, D. C., & Bondi, M. W. (2012) · The Clinical Neuropsychologist · doi:10.1080/13854046.2012.728626 · Cited by 44
Neuropathology of the Alzheimer's continuum: an update
Jellinger, K. A. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3050 · Cited by 52
Prabha, S., Sajad, M., Hasan, G. M., Islam, A., Hassan, M. I., & Thakur, S. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102476 · Cited by 44
Kouri, N., Oshima, K., Takahashi, M., Murray, M. E., Ahmed, Z., Parisi, J. E., Yen, S. H., & Dickson, D. W. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1087-8 · Cited by 44
Self-citationQuantitative T2 mapping of white matter: applications for ageing and cognitive decline
Knight, M. J., McCann, B., Tsivos, D., Dillon, S., Coulthard, E. J., & Kauppinen, R. A. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/15/5587 · Cited by 44
Leuzy, A., Binette, A. P., Vogel, J. W., Klein, G., Borroni, E., Tonietto, M., Strandberg, O. T., Mattsson, N., Palmqvist, S., Pontecorvo, M. J., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.1067 · Cited by 43
Self-citationAlzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Thal, D. R., Poesen, K., Vandenberghe, R. R., & Meyer, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00819-y · Cited by 55
A method for inferring regional origins of neurodegeneration
Torok, J., Maia, P. D., Powell, F., Pandya, S., & Raj, A. (2017) · Brain · doi:10.1093/brain/awx371 · Cited by 42
Diffuse Lewy body disease manifesting as corticobasal syndrome
Kasanuki, K., Josephs, K. A., Ferman, T. J., Murray, M. E., Koga, S., Konno, T., Sakae, N., Parks, A. C., Uitti, R. J., van Gerpen, J. A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005828 · Cited by 41
Self-citationPrecision diagnostics based on machine learning-derived imaging signatures
Davatzikos, C. A., Sotiras, A., Yong Fan, A., Habes, M., Erus, G., Rathore, S., Bakas, S., Chitalia, R., Gastounioti, A., & Despina Kontos, B. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.04.012 · Cited by 42
Rodríguez, J. L., Oltmer, J., Greve, D. N., Williams, E. M., Slepneva, N., Wang, R., Champion, S., Lang-Orsini, M., Fischl, B. R., Frosch, M. P., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215567 · Cited by 44
Metadata
- Authors
- Murray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W.
- Affiliations
- Mayo Clinic (US)
- Mount Sinai Medical Center (US)
- Corresponding author
- Dickson, Dennis W
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 10
- Issue
- 9
- Pages
- 785-796
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC3175379
- OpenAlex
- W2075444764
- Cited by
- 972
- References
- 44
- Citations by year
- 2026: 60 · 2025: 80 · 2024: 78 · 2023: 96 · 2022: 80 · 2021: 104 · 2020: 70 · 2019: 73 · 2018: 56 · 2017: 50 · 2016: 55 · 2015: 37 · 2014: 36 · 2013: 54 · 2012: 35
- FWCI
- 29.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health
- National Institute on Aging (P50‐AG16574, U01AG06786, P50 AG215711, P01AG03949, U01AG006786, P01AG003949, R21AG038736, P50AG025711, P01AG017216, P50AG016574)
- National Institute of Neurological Disorders and Stroke (P50NS072187)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, Braak staging, hippocampal sparing, hippocampal atrophy, tau pathology, clinical features, atypical Alzheimer's disease, sex differences, age at death, genetic risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Limbic System, Male, Middle Aged, Retrospective Studies, Cohort Studies, Neurofibrillary Tangles, tau Proteins, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
